Jia Yao

Dr. Jia Yao


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2023 in Gut and Liver
Verified
Journal Article
Open access
PDF file
JYJia Yao
Jia Yao
YJYaqiu Ji
Yaqiu Ji
TLTian Liu
Tian Liu
JBJinjia Bai
Jinjia Bai
HWHan Wang
Han Wang
XZXiaoshuang Zhou
Xiaoshuang Zhou
Jia Yao, Yaqiu Ji, Tian Liu, Jinjia Bai, Han Wang, Ruoyu Yao, Juan Wang, Xiaoshuang Zhou. Gut and Liver 2024;18:520-30. https://doi.org/10.5009/gnl220449

1 March 2021 in Nutrition
Verified
Journal Article
Closed access
XRXiaojing Ren
Xiaojing Ren
SHShasha Hao
Shasha Hao
CYChuanli Yang
Chuanli Yang
LYLili Yuan
Lili Yuan
XZXiaoshuang Zhou
Xiaoshuang Zhou
JYJia Yao
Jia Yao

2 May 2025 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
SWShuang Wang
Shuang Wang
LSLiying Song
Liying Song
YSYuanjie Sun
Yuanjie Sun
HZHaonan Zhou
Haonan Zhou
JYJia Yao
Jia Yao
Objective: To combine pharmacovigilance and network toxicology methods to observe the acute pancreatitis (AP) following the use of antipsychotics, and potential toxic mechanisms, and to provide a reference for the safe use of drugs.Methods: This study combined pharmacovigilance methods using real-world data and network toxicology methods to investigate AP associated with antipsychotics and the potential toxicological mechanism involved. First, the reports of antipsychotics were extracted from the US FDA Adverse Event Reporting System (FAERS), and the signals of AP were detected by four pharmacovigilance algorithms. The gene targets of drugs were predicted using multiple databases. The disease targets of AP were determined by bioinformatics methods. Protein-protein interaction (PPI) analysis was conducted using STRING database, gene ontology (GO) and Kyoto encyclopedia of genes and genomes (KEGG) analysis were also performed through R software. Molecular docking was applied to test the molecular affinity using AutoDock.Results: The signal intensity of AP was statistically significant in olanzapine, quetiapine, and fluphenazine. Due to the small number of reports associated with AP AEs on fluphenazine, our subsequent studies mainly focused on olanzapine and quetiapine. The results of stratification analysis suggested robustness of our results. Age ≤65, female, and weight >80 kg were identified as risk factors of the development of AP in patients receiving olanzapine, while weight >80 kg and age ≤65 were risk factors of that in patients receiving quetiapine. Network toxicology analysis and molecular docking suggested that olanzapine and quetiapine may exert their toxic effects through acting on hub genes.Conclusion: The pharmacovigilance analysis investigated the signal intensity, clinical features, risk factors, and onset time of AP associated with olanzapine and quetiapine. Network toxicology analysis suggested that the toxic effects of olanzapine and quetiapine may be related to their hub genes.

1 May 2019 in Therapeutics and Clinical Risk Management
Verified
Journal Article
Open access
PDF file
JYJia Yao
Jia Yao
WHWeijia Han
Weijia Han
XRXiaojing Ren
Xiaojing Ren
LYLili Yuan
Lili Yuan
JXJun Xu
Jun Xu
ZDZhongping Duan
Zhongping Duan

Aim:
Malnutrition is one of the most common complications in patients with liver cirrhosis. Abnormal energy substrate metabolism may contribute to aggravation of malnutrition. Late evening snack (LESs) supplementation has been recommended as an intervention to reduce starvation time and improve nutritional status. Published studies have analyzed the effect of LESs on the branched-chain amino acid (BCAA)/tyrosine ratio (BTR) and oxidation rate of fat and carbohydrate in patients with liver cirrhosis. Methods: We searched PubMed, Cochrane Library, Web of Science and Embase for relevant research from January 2000 to October 2018. The primary outcome for this analysis was changes in BTR and fat and carbohydrate oxidation in patients with liver cirrhosis. Results: A total of 9 articles, containing 211 patients, were included in this analysis. The results supported that supplementation with BCAA-enriched LESs improved BTR, and long-term supplementation with BCAAs (>1 month) may be more beneficial than short-term supplementation (<1 month) in patients with liver cirrhosis. In addition, supplementation with BCAAs may increase the oxidation rate of carbohydrates and decrease the oxidation rate of fat. Furthermore, compared with liquid-enriched LESs, BCAA was a better choice for increasing the oxidation of carbohydrates and decreasing the rate of fat oxidation. Conclusion: BCAA-enriched LES supplementation is an appropriate nutritional intervention to improve abnormal energy substrate metabolism, which may improve malnutrition in patients with liver cirrhosis. Further research is needed on the long-term benefit and improved survival in patients with liver cirrhosis.

4 July 2025 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
XQXiaojing Qin
Xiaojing Qin
SWShuang Wang
Shuang Wang
ZYZhanyao Yan
Zhanyao Yan
NZNinghui Zhao
Ninghui Zhao
JYJia Yao
Jia Yao
Acute-on-chronic liver failure (ACLF) is a clinical syndrome that manifests as acute deterioration of liver function due to a series of etiologies and triggers in patients with pre-existing chronic liver diseases. Systemic inflammatory response is the major feature of ACLF. Gut microbiota dysbiosis impairs the intestinal barrier, facilitating the translocation of microorganisms and their metabolites into the liver and thereby exacerbating liver inflammation and disease progression. Recent studies have revealed that bacterial outer membrane vesicles (OMVs) derived from gut microbiota act as key mediators in microbiota-host cell communication. This article elucidates the possible roles of OMVs in ACLF inflammation and their underlying mechanisms.

31 March 2021 in Journal of Clinical and Translational Hepatology
Verified
Journal Article
Open access
XZXiaoshuang Zhou
Xiaoshuang Zhou
YLYidong Li
Yidong Li
YJYaqiu Ji
Yaqiu Ji
TLTian Liu
Tian Liu
NZNinghui Zhao
Ninghui Zhao
JYJia Yao
Jia Yao
Programmed cell death-1 (PD-1) plays an important role in downregulating T lymphocytes but the mechanisms are still poorly understood. This study aimed to explore the role of PD-1 in CD8+ T lymphocyte dysfunction in hepatitis B virus (HBV)-related acute-on-chronic liver failure (ACLF).